These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 17453960)

  • 1. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal pathogenesis of Staphylococcus aureus strain Newman.
    Dajcs JJ; Austin MS; Sloop GD; Moreau JM; Hume EB; Thompson HW; McAleese FM; Foster TJ; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1109-15. PubMed ID: 11923253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
    Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
    Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida.
    Traidej M; Caballero AR; Marquart ME; Thibodeaux BA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):190-6. PubMed ID: 12506074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
    Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
    Pillar CM; Hazlett LD; Hobden JA
    Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastase and alkaline protease production by Pseudomonas aeruginosa strains: comparison of two procedures.
    Yagci A; Tuc Y; Soyletir G
    New Microbiol; 2002 Apr; 25(2):223-9. PubMed ID: 12019729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa proteases and corneal virulence.
    Hobden JA
    DNA Cell Biol; 2002; 21(5-6):391-6. PubMed ID: 12167241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
    Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
    Reed JM; O'Callaghan RJ; Girgis DO; McCormick CC; Caballero AR; Marquart ME
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):604-8. PubMed ID: 15671288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus corneal virulence in a new topical model of infection.
    Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.
    Matsumoto K; Shams NB; Hanninen LA; Kenyon KR
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):1945-53. PubMed ID: 8491548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein D in Pseudomonas aeruginosa keratitis.
    McCormick CC; Hobden JA; Balzli CL; Reed JM; Caballero AR; Denard BS; Tang A; O'Callaghan RJ
    Ocul Immunol Inflamm; 2007; 15(5):371-9. PubMed ID: 17972221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
    O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.